Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Senetek (SNTK) -- Ignore unavailable to you. Want to Upgrade?

To: inchingup who wrote (76)	11/7/2007 3:53:58 PM
From: jh2006	Read Replies (1) \| Respond to of 101

I see your point but I think those are low estimates. Next year, it looks like there are 3 products to be sold: skin lightening (Asia), skin aging and acne rosacea. I had a friend die from a brain tumor about 2 months ago. There was nothing they could do except give him pain meds. He just waited to die from it. The RNAi drug is in phase one trials in Europe. Senetek isn't really just a stock for me anymore. I see hope for a treatment for others.